REG-Convatec Group PLC Convatec Group PLC: Director/ PDMR Shareholding

ConvaTecAnnouncement

30/09/2022 13:30

============

   Convatec Group PLC (CTEC)
   Convatec Group PLC: Director/ PDMR Shareholding

   30-Sep-2022 / 13:19 GMT/BST
   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   30 September 2022

                               Convatec Group Plc
                         ("Convatec" or "the Company")

                          Director/ PDMR Shareholding 

   The Company has  been notified of  the following transaction  by a  Person
   Discharging Managerial Responsibility  ("PDMR") in ordinary  shares of  10
   pence each in the share capital of the Company ("Shares").

   On 30 September 2022, Constantin Coussios, Non-Executive Director and
   PDMR, purchased 9,861 Shares of 10 pence in the Company. Constantin
   Coussios’ resulting shareholding is 18,301 Shares.

   NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
      MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

   1  Details of the person discharging managerial responsibilities/person
      closely associated
   a) Name                            Constantin Coussios
   2  Reason for the notification
   a) Position/Status                 Non-Executive Director
   b) Initial notification/Amendment  Initial notification
   3  Details of the issuer, emission allowance market participant, auction
      platform, auctioneer or auction monitor
   a) Name                            Convatec Group Plc
   b) LEI                             213800LS272L4FIDOH92
      Details of the transaction(s): section to be repeated for (i) each type
   4  of instrument; (ii) each type of transaction; (iii) each date; and (iv)
      each place where transactions have been conducted
                                      Ordinary share of 10p each in Convatec
      Description of the financial    Group Plc
   a) instrument, type of instrument
                                       
      Identification code
                                      GB00BD3VFW73
                                      Purchase of Ordinary shares of 10p each
   b) Nature of the transaction       in Convatec Group Plc

                                       
                                      Price(s)          Volume(s)
   c) Price(s) and volume(s)
                                      £2.04892          9,861
      Aggregated information           

   d) - Aggregated volume             N/A

      - Price                         N/A
   e) Date of the transaction         2022-09-30
   f) Place of the transaction        London Stock Exchange, Main Market
                                      (XLON)
                                                                    

    

    

   Enquiries 

   Analysts and Investors 

   Kate Postans, VP Investor Relations,
   Convatec                                                            +44
   (0)782 644 7807 

    1 ir@convatec.com 

    

   Media 

   Buchanan: Charles Ryland / Chris Lane              
                                                               +44 (0)207 466
   5000                                            

   Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

    

   About Convatec 
    

   Pioneering trusted medical solutions to improve the lives we touch:
   Convatec is a FTSE 100 global medical products and technologies company,
   focused on solutions for the management of chronic conditions, with
   leading positions in advanced wound care, ostomy care, continence and
   critical care, and infusion care. Group revenues in 2021 were over $2
   billion. With around 10,000 colleagues, we provide our products and
   services in over 100 countries, united by a promise to be forever caring.
   Our products provide a range of benefits, from infection prevention and
   protection of at-risk skin, to improved patient outcomes and reduced care
   costs. To learn more about Convatec, please visit
    2 http://www.convatecgroup.com

    

   ══════════════════════════════════════════════════════════════════════════

   ISIN:          GB00BD3VFW73
   Category Code: DSH
   TIDM:          CTEC
   LEI Code:      213800LS272L4FIDOH92
   Sequence No.:  191553
   EQS News ID:   1454167


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    3 fncls.ssp?fn=show_t_gif&application_id=1454167&application_name=news&site_id=reuters8

References

   Visible links
   1. mailto:ir@convatec.com
   2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=26f8de477e9a42123589f91471356e0b&application_id=1454167&site_id=reuters8&application_name=news


============